Mar 07, 2024 / 01:30PM GMT
Operator
Hello, and welcome to the Phathom Pharmaceuticals Fourth Quarter and Full Year 2023 earnings conference call. At this time, all participants are in a listen only mode. After the presentation there will be a question and answer session to ask a question. During the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one again. Please be advised today's conference is being recorded. With that, I would like to turn the conference over to Eric separately, SatCon's Head of Investor Relations. Please go ahead.
Eric Sciorilli - Phathom Pharmaceuticals, Inc. - Head of IR
Thank you, operator. Hello, everyone, and thank you for joining us this morning to discuss Falcon's Fourth Quarter and Full Year 2023 results. This morning's presentation will include remarks from Terrie Curran, our President and CEO, Martin Gilligan, our Chief Commercial Officer, and Molly Henderson, our Chief Financial Officer, renewable C, our Chief Operating Officer, will
Q4 2023 Phathom Pharmaceuticals Inc Earnings Call Transcript
Mar 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers